Clinical Trial Update: TIMELY-PrädiktoR Prospective Study

View source ↗

Summary

The TIMELY-PrädiktoR prospective study, sponsored by Dr. Boris Schmitz, is currently recruiting patients with Coronary Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Dr. Boris Schmitz | Conditions: Coronary Artery Disease | Status: RECRUITING